Market and technology due diligence for acquisition in the in-vitro diagnostic market

We helped a client in the private equity space to conduct market due diligence for a target in the diagnostic market with a portfolio of ingredients for diagnostic assay (nucleic acid isolation, purification, amplification, etc.). We segmented the market by technology type, application and end-user. We characterised the key trends that shape the dynamic of each segment. A technology review of the state-of-the-art and emerging technologies was conducted to assess the risks and entry barriers of market segments where the provider was operating. We recommended a range of upsides and high-priority opportunities for strategic fit and future growth.